BBOT
BridgeBio Oncology Therapeutics, Inc.
3.60$
-7.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | – | – | +126.1% | +193.3% | |
| – | – | – | -98.4% | +2,062.6% | |
| – | – | – | – | – | |
| – | – | – | -88.2% | +1,136.7% | |
| – | – | – | +6,424.8% | – | |
| – | – | – | +238.3% | +105.6% | |
| – | – | – | +654.6% | +20,093.2% | |
| – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.